首页> JAMA oncology.> Incidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer A Systematic Review and Meta-analysis

Incidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer A Systematic Review and Meta-analysis

导出原文传递

翻译打印收藏纠错

第一作者： Jfri, Abdulhadi

作者： Jfri, Abdulhadi ^[1] ; Meltzer, Rachel ; Mostaghimi, Arash ; LeBoeuf, Nicole ; Guggina, Lauren

作者单位： Harvard University,Harvard Med Sch ^[1]

关键词 PHASE-II TRIAL ADVANCED BREAST-CANCER PHOSPHATIDYLINOSITOL 3-KINASE DOUBLE-BLIND METASTATIC HEAD PLACEBO PX-866 BUPARLISIB PACLITAXEL FULVESTRANT

发布时间 2023-02-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA oncology.

2022年8卷11期

1635-1643页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

JAMA oncology.

2022年8卷11期

1635-1643页

检索历史清除

Incidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer A Systematic Review and Meta-analysis

JAMA oncology.

相似文献

同项目论文

JAMA oncology.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Incidence of Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors as Adjuvant Therapy in Patients With Cancer A Systematic Review and Meta-analysis

JAMA oncology.

相似文献

同项目论文

JAMA oncology.

相关期刊

检索历史清除